|
Preparing for CXL
The modern way of Cross-Linking
|
The following videos give you insights about step to prepare your C-Eye device for a cross-linking procedure performed at the slit lamp.
The modern way of Cross-Linking
The following videos give you insights about step to prepare your C-Eye device for a cross-linking procedure performed at the slit lamp.
EMAGine's CEO Nikki Hafezi, a “Top 40 under 40” PowerList awardee, tells how innovation and perseverance allowed her to successfully establish the C-Eye device (corneal cross-linking at the slit lamp) in the midst of the COVID-19 crisis. The C-Eye device is seen by many as a game changer in keratoconus treatment.
Read the story in the march 2021 edition of “The Ophthalmologist”: theophthalmologist.com/subspecialties/when-the-rubber-hits-the-road
See here an introduction video to the C-Eye device and Ribo-Ker, EMAGine’s riboflavin solution. The device enables the ophthalmologist to treat keratoconus and corneal infections at the slit lamp. EMAGine the possibilities.
#ophthalmology #innovation #keratoconus #keratitis #cornea
vimeo.com/517046984
Cross-Linking on Zeiss slit lamps is now possible. EMAGine announces two additional slit lamps that are compatible with the C-Eye device: Carl Zeiss’ SL-120 and SL-220. The list now comprises a total of 34 different slit lamp models, covering most of the commonly used slit lamps in modern ophthalmology.
www.emagine-eye.com/blog/2021/02/22/car-zeiss-slit-lamp-models-compatible-with-c-eye/
Carl Zeiss slit lamp models compatible with C-Eye - EMAGine
www.emagine-eye.com
Cross-linking on Zeiss slit lamps becomes possible using the Carl Zeiss SL-120 and SL-220 slit lamps.
Another successful clinical study on the effect of PACK-CXL on infectious keratitis from Dr. Rosario Gulias-Cañizo from Mexico:. The body of evidence is steadily increasing, see here: pubmed.ncbi.nlm.nih.gov/33376299/
#cornealulcer #keratitis #CornealCrossLinking #cornea
pubmed.ncbi.nlm.nih.gov
As adjuvant therapy to standard antimicrobial treatment, PACK-CXL improves the outcomes in patients with treatment-resistant corneal ulcers.
This content isn't available right now
When this happens, it's usually because the owner only shared it with a small group of people, changed who can see it or it's been deleted.